Drug intelligence / Profile preview

Nuloera

Development stage: Unknown
Lead developer: Jain Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

Nuloera is a topical dermatological formulation developed and marketed by Jain Pharmaceuticals. It is primarily utilized as a moisturizing and skin-soothing agent for the management of various dermatological conditions, including xerosis (dry skin), dermatitis, and general skin irritation. The formulation typically combines the hydrating and anti-inflammatory properties of **Aloe vera** extract with the antioxidant effects of **Vitamin E** (Tocopheryl Acetate). By acting as both an emollient and a humectant, Nuloera helps to restore the skin's natural lipid barrier, prevent transepidermal water loss, and protect skin cells from oxidative stress. It is a commercially available product in the Indian pharmaceutical market.

Brand names: Nuloera
Other names: Nuloera CreamNuloera Lotion

Beyond the preview

Go deeper on Nuloera.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuloera.

Explore the full profile